当前位置: X-MOL 学术Cancer Cell › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Stabilization of the c-Myc Protein by CAMKIIγ Promotes T Cell Lymphoma.
Cancer Cell ( IF 48.8 ) Pub Date : 2017-07-10 , DOI: 10.1016/j.ccell.2017.06.001
Ying Gu 1 , Jiawei Zhang 1 , Xiaoxiao Ma 2 , Byung-Wook Kim 2 , Hailong Wang 1 , Jinfan Li 3 , Yi Pan 4 , Yang Xu 5 , Lili Ding 1 , Lu Yang 6 , Chao Guo 6 , Xiwei Wu 6 , Jun Wu 7 , Kirk Wu 1 , Xiaoxian Gan 1 , Gang Li 1 , Ling Li 8 , Stephen J Forman 9 , Wing-Chung Chan 10 , Rongzhen Xu 5 , Wendong Huang 2
Affiliation  

Although high c-Myc protein expression is observed alongside MYC amplification in some cancers, in most cases protein overexpression occurs in the absence of gene amplification, e.g., T cell lymphoma (TCL). Here, Ca2+/calmodulin-dependent protein kinase II γ (CAMKIIγ) was shown to stabilize the c-Myc protein by directly phosphorylating it at serine 62 (S62). Furthermore, CAMKIIγ was shown to be essential for tumor maintenance. Inhibition of CAMKIIγ with a specific inhibitor destabilized c-Myc and reduced tumor burden. Importantly, high CAMKIIγ levels in patient TCL specimens correlate with increased c-Myc and pS62-c-Myc levels. Together, the CAMKIIγ:c-Myc axis critically influences the development and maintenance of TCL and represents a potential therapeutic target for TCL.

中文翻译:


CAMKIIγ 对 c-Myc 蛋白的稳定促进 T 细胞淋巴瘤。



尽管在一些癌症中观察到高c-Myc蛋白表达与MYC扩增同时发生,但在大多数情况下,蛋白过度表达发生在没有基因扩增的情况下,例如T细胞淋巴瘤(TCL)。此处,Ca 2+ /钙调蛋白依赖性蛋白激酶 II γ (CAMKIIγ) 通过直接磷酸化丝氨酸 62 (S62) 来稳定 c-Myc 蛋白。此外,CAMKIIγ被证明对于肿瘤维持至关重要。用特定抑制剂抑制 CAMKIIγ 会破坏 c-Myc 的稳定性并减少肿瘤负荷。重要的是,患者 TCL 标本中的高 CAMKIIγ 水平与 c-Myc 和 pS62-c-Myc 水平升高相关。总之,CAMKIIγ:c-Myc 轴严重影响 TCL 的发育和维持,并代表 TCL 的潜在治疗靶点。
更新日期:2017-07-11
down
wechat
bug